JP2013510081A - 向知性作用を有する2−(5−メチル−2−オキソ−4−フェニル−ピロリジン−1−イル)−アセトアミドの4r,5s−エナンチオマー - Google Patents
向知性作用を有する2−(5−メチル−2−オキソ−4−フェニル−ピロリジン−1−イル)−アセトアミドの4r,5s−エナンチオマー Download PDFInfo
- Publication number
- JP2013510081A JP2013510081A JP2012535876A JP2012535876A JP2013510081A JP 2013510081 A JP2013510081 A JP 2013510081A JP 2012535876 A JP2012535876 A JP 2012535876A JP 2012535876 A JP2012535876 A JP 2012535876A JP 2013510081 A JP2013510081 A JP 2013510081A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oxo
- phenyl
- pyrrolidin
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
【選択図】なし
Description
a)キラル2,2’−シクロプロピリデン−ビス−オキサゾリンと、トリフル酸マグネシウムと、有機塩基とから成る錯体触媒の存在下での、マロン酸ジエチルへの、2−ニトロプロプ−1−エニルベンゼンの添加;
b)ラネーニッケル存在下でのジエチル2−(2−ニトロ−1R−フェニルプロピル)マロネートの水素化による、ジエチル2−(2−ニトロ−1R−フェニルプロピル)マロネートの、エナンチオマーの5S−メチル−4R−フェニルピロリジン−2−オンへの変換、エチル5−メチル−2−オキソ−4(R)−フェニルピロリジン−3(S)−カルボキシラートのジアステレオ異性体混合物の、別々の5S,4R−および5R,4−エナンチオマーへのラセミ分割、エチル5(S)−メチル−2−オキソ−4(R)−フェニルピロリジン−3(S)−カルボキシラートの脱炭酸;
c)5S−メチル−4R−フェニルピロリジン−2−オンのアミド基中の水素の、適切な有機溶媒中のナトリウムイオンとの置換;
d)N−金属化5S−メチル−4R−フェニルピロリジン−2−オンの、適切な有機溶媒中のハロ酢酸エステルを用いたN−アルキル化;
e)エチル2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセテートの、適切な溶媒中のアンモニアを用いたアミド化。
*p<0.05は対生理食塩水対照群、#p<0.05は対2−(4R−フェニル−2−オキソピロリジン−1−イル)アセトアミド−処理群、そして$p<0.05は対ラセミ化合物2−(5−メチル−2−オキソ−4−フェニル−ピロリジン−1−イル)−アセトアミド−処理群;それぞれn≧10
Claims (16)
- 医薬品としての利用のための、2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセトアミド。
- 向知性薬としての利用のための、2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセトアミド。
- 認知力改善薬としての利用のための、2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセトアミド。
- 認知障害の治療における利用のための、2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセトアミド。
- 以下のステップを含む、請求項1に記載の化合物(I)の調製方法:
a)トリフル酸マグネシウムと有機塩基とから成る錯体触媒の存在下での、マロン酸ジエチルへの、2−ニトロプロプ−1−エニルベンゼンの添加;
b)水素圧力が3と60atmの間にある、ラネーニッケル存在下でのジエチル2−(2−ニトロ−1R−フェニルプロピル)マロネートの水素化による、ジエチル2−(2−ニトロ−1R−フェニルプロピル)マロネートの、エナンチオマーの5S−メチル−4R−フェニルピロリジン−2−オンへの変換、エチル5−メチル−2−オキソ−4(R)−フェニルピロリジン−3(S)−カルボキシラートのジアステレオ異性体混合物の、別々の5S,4R−および5R,4−エナンチオマーへのラセミ分割、エチル5(S)−メチル−2−オキソ−4(R)−フェニルピロリジン−3(S)−カルボキシラートの脱炭酸;
c)5S−メチル−4R−フェニルピロリジン−2−オンのアミド基中の水素の、適切な有機溶媒中のナトリウムイオンとの置換;
d)N−金属化5S−メチル−4R−フェニルピロリジン−2−オンの、適切な有機溶媒中のハロ酢酸エステルを用いたN−アルキル化;
e)エチル2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセテートの、適切な溶媒中のアンモニアを用いたアミド化。 - ステップa)において、キラル2,2’−シクロプロピリデン−ビス(オキサゾリン)が、(3aR,3’aR,8aS,8’aS)−2,2’−シクロプロピリデンビス−[3a,8a]−ジヒドロ−8H−インデノ−[1,2−d]−オキサゾールである、請求項6に記載の方法。
- ステップa)において、有機塩基が、モルホリン、N−メチルモルホリン、1,1,3,3−テトラメチルグアニジン、およびそれらの混合物を含む群から選択される、請求項6に記載の方法。
- ステップb)において、エチル5(R,S)−メチル−2−オキソ−4(R)−フェニルピロリジン−3(S)−カルボキシラートのジアステレオ異性体混合物の結晶化によるラセミ分割のための有機溶媒が、メタノール、エタノール、イソプロパノール、およびそれらの混合物を含む群から選択される、請求項6に記載の方法。
- ステップb)において、エチル5(S)−メチル−2−オキソ−4(R)−フェニルピロリジン−3(S)−カルボキシラートの加水分解のための塩基が、水酸化ナトリウムと水酸化カリウムを含む群から選択される、請求項6に記載の方法。
- ステップb)において、p−トルエンスルホン酸の存在下での酢酸イソプロピル溶液中の5(S)−メチル−2−オキソ−4(R)−フェニルピロリジン−3(S)−カルボキシラートの脱炭酸の温度が、50℃と88℃の間である、請求項6に記載の方法。
- ステップc)において、ナトリウムイオンが、水素化ナトリウムあるいはナトリウムエチラートによって、5S−メチル−4R−フェニルピロリジン−2−オンのアミド基に導入される、請求項6に記載の方法。
- ステップd)において、ハロ酢酸エステルが、ブロモ酢酸エステルあるいはクロロ酢酸エステルの群から選択される、請求項6に記載の方法。
- ステップe)において、エチル2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセテートのアミド化が、アンモニア水中であるいはアンモニア水と適切な有機溶媒との混合物中で実現される、請求項6に記載の方法。
- ステップe)において、エチル2−(5S−メチル−2−オキソ−4R−フェニル−ピロリジン−1−イル)−アセテートのアミド化が、適切な有機溶媒中で気体アンモニアを用いたその飽和によって実現される、請求項6に記載の方法。
- 反応に用いられる有機溶媒が、メタノール、エタノール、プロパノール、クロロホルム、塩化メチレン、酢酸エチル、および1,4−ジオキサンを含む群から選択される、請求項14または15に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-09-193A LV14346B (lv) | 2009-11-05 | 2009-11-05 | 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti |
LVP-09-193 | 2009-11-05 | ||
PCT/EP2010/066767 WO2011054888A1 (en) | 2009-11-05 | 2010-11-04 | 4r,5s-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2013510081A true JP2013510081A (ja) | 2013-03-21 |
Family
ID=43466928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012535876A Pending JP2013510081A (ja) | 2009-11-05 | 2010-11-04 | 向知性作用を有する2−(5−メチル−2−オキソ−4−フェニル−ピロリジン−1−イル)−アセトアミドの4r,5s−エナンチオマー |
Country Status (18)
Country | Link |
---|---|
US (2) | US8791273B2 (ja) |
EP (1) | EP2496555B1 (ja) |
JP (1) | JP2013510081A (ja) |
CN (1) | CN102596905B (ja) |
AR (1) | AR078904A1 (ja) |
CA (1) | CA2780040C (ja) |
CY (1) | CY1114881T1 (ja) |
DK (1) | DK2496555T3 (ja) |
EA (1) | EA019890B1 (ja) |
ES (1) | ES2434024T3 (ja) |
HR (1) | HRP20131086T1 (ja) |
LV (1) | LV14346B (ja) |
PL (1) | PL2496555T3 (ja) |
PT (1) | PT2496555E (ja) |
RS (1) | RS53014B (ja) |
SI (1) | SI2496555T1 (ja) |
UA (1) | UA107367C2 (ja) |
WO (1) | WO2011054888A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018522019A (ja) * | 2015-08-03 | 2018-08-09 | ラトビアン インスティテュート オブ オーガニック シンセシスLatvian Institute Of Organic Synthesis | 発作の予防または治療のための2−(5s−メチル−2−オキソ−4r−フェニル−ピロリジン−1−イル)−アセトアミドを含む医薬組成物 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2711655C1 (ru) * | 2019-09-13 | 2020-01-20 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации | Способ крупномасштабного синтеза калиевой соли 2-[2-(2-оксо-4-фенилпирролидин-1-ил)ацетамидо]этансульфокислоты |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4947366A (ja) * | 1972-05-03 | 1974-05-08 | ||
WO2007104780A2 (en) * | 2006-03-16 | 2007-09-20 | Akciju Sabiedriba 'olainfarm' | N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1040747C (zh) * | 1994-05-07 | 1998-11-18 | 中国科学院昆明植物研究所 | N-取代基-4-取代苯基-5-烷基-5-取代苄基吡咯烷酮-2,其中间体,其合成方其法及应用 |
US7608636B2 (en) * | 2000-12-28 | 2009-10-27 | Hamilton Pharmaceuticals, Inc. | Medicines for treatment and prevention of neurogenic pain |
WO2005061454A1 (ja) * | 2003-12-24 | 2005-07-07 | Hideki Ohyama | 脳血管障害慢性期の重度失語症に対する治療剤又は治療方法 |
GB0412019D0 (en) * | 2004-05-28 | 2004-06-30 | Novartis Ag | Organic compounds |
-
2009
- 2009-11-05 LV LVP-09-193A patent/LV14346B/lv unknown
-
2010
- 2010-04-11 UA UAA201206776A patent/UA107367C2/ru unknown
- 2010-11-04 SI SI201030416T patent/SI2496555T1/sl unknown
- 2010-11-04 CA CA2780040A patent/CA2780040C/en active Active
- 2010-11-04 RS RS20130474A patent/RS53014B/en unknown
- 2010-11-04 PL PL10776339T patent/PL2496555T3/pl unknown
- 2010-11-04 EA EA201200536A patent/EA019890B1/ru unknown
- 2010-11-04 EP EP10776339.3A patent/EP2496555B1/en active Active
- 2010-11-04 JP JP2012535876A patent/JP2013510081A/ja active Pending
- 2010-11-04 AR ARP100104073A patent/AR078904A1/es not_active Application Discontinuation
- 2010-11-04 ES ES10776339T patent/ES2434024T3/es active Active
- 2010-11-04 CN CN201080050216.9A patent/CN102596905B/zh not_active Expired - Fee Related
- 2010-11-04 PT PT107763393T patent/PT2496555E/pt unknown
- 2010-11-04 DK DK10776339.3T patent/DK2496555T3/da active
- 2010-11-04 WO PCT/EP2010/066767 patent/WO2011054888A1/en active Application Filing
- 2010-11-04 US US13/508,184 patent/US8791273B2/en not_active Expired - Fee Related
-
2013
- 2013-11-13 HR HRP20131086AT patent/HRP20131086T1/hr unknown
- 2013-11-27 CY CY20131101066T patent/CY1114881T1/el unknown
-
2014
- 2014-06-16 US US14/305,382 patent/US20140296317A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4947366A (ja) * | 1972-05-03 | 1974-05-08 | ||
WO2007104780A2 (en) * | 2006-03-16 | 2007-09-20 | Akciju Sabiedriba 'olainfarm' | N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use |
Non-Patent Citations (4)
Title |
---|
JPN5013002658; BERESTOVITSKAYA,V.M.: 'SYNTHESIS AND STRUCTURE OF 2-OXO-1-PYRROLIDINYLACETAMIDES' PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON THE CHEMISTRY AND BIOLOGICAL ACTIVITY 以下備考 V1, 20011009, P216-220 * |
JPN6014026052; OKINO, Tomotaka et al: 'Enantio- and Diastereoselective Michael Reaction of1,3-Dicarbonyl Compounds to Nitroolefins Catalyze' Journal of the American Chemical Society Vol.127, No.1, 2005, p.119-125 * |
JPN6014026055; GUDASHEVA, T. A. et al: 'Peptide analogs of piracetam as ligands of putative nootropic receptors' Khimiko-Farmatsevticheskii Zhurnal Vol.19, No.11, 1985, p.1322-1329 * |
JPN6015010589; PEI, Zhonghua et al: 'Discovery and Structure-Activity Relationships of Piperidinone- and Piperidine-Constrained Phenethyl' Journal of Medicinal Chemistry Vol.50, No.8, 2007, p.1983-1987 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018522019A (ja) * | 2015-08-03 | 2018-08-09 | ラトビアン インスティテュート オブ オーガニック シンセシスLatvian Institute Of Organic Synthesis | 発作の予防または治療のための2−(5s−メチル−2−オキソ−4r−フェニル−ピロリジン−1−イル)−アセトアミドを含む医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
EP2496555B1 (en) | 2013-08-28 |
CA2780040C (en) | 2014-04-08 |
CY1114881T1 (el) | 2016-12-14 |
US8791273B2 (en) | 2014-07-29 |
EA201200536A1 (ru) | 2012-09-28 |
CA2780040A1 (en) | 2011-05-12 |
AR078904A1 (es) | 2011-12-14 |
LV14346B (lv) | 2011-07-20 |
DK2496555T3 (da) | 2013-11-11 |
US20120215010A1 (en) | 2012-08-23 |
UA107367C2 (xx) | 2014-12-25 |
WO2011054888A1 (en) | 2011-05-12 |
CN102596905B (zh) | 2014-07-16 |
PL2496555T3 (pl) | 2014-01-31 |
LV14346A (lv) | 2011-05-20 |
PT2496555E (pt) | 2013-12-02 |
EP2496555A1 (en) | 2012-09-12 |
CN102596905A (zh) | 2012-07-18 |
RS53014B (en) | 2014-04-30 |
SI2496555T1 (sl) | 2013-12-31 |
US20140296317A1 (en) | 2014-10-02 |
ES2434024T3 (es) | 2013-12-13 |
HRP20131086T1 (hr) | 2013-12-20 |
EA019890B1 (ru) | 2014-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101282464B1 (ko) | 나트륨 채널 조절제로서의 프롤린아미드 유도체 | |
ES2553968T3 (es) | Moduladores del receptor NMDA y sus usos | |
KR101898829B1 (ko) | 마이크로솜 프로스타글란딘 e2 신타제-1을 억제하는데 유용한 신규한 메틸-피페리딘 화합물 | |
DE60113514T2 (de) | 2-oxo-1-pyrrolidinderivate, verfahren zu ihrer herstellung und ihre verwendung | |
DE602004006431T2 (de) | Derivate von n-äheteroaryl(piperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika | |
EP1706376B1 (en) | Imidazole derivatives, processes for preparing them and their uses | |
WO2014100438A1 (en) | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors | |
ES2390455T3 (es) | Procedimiento para la preparación de derivados de 2-oxo-1-pirrolidina | |
EA014668B1 (ru) | Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона | |
BR112014031565B1 (pt) | Derivado de indanossulfamida inovador | |
WO2008042755A2 (en) | Inhibitors of cognitive decline | |
ES2331162T3 (es) | Proceso para la preparacion de dorzolamida. | |
CN100418525C (zh) | 对钙通道α-2-δ亚基具有亲合力的脯氨酸衍生物 | |
CA2926754C (en) | Piperazine derivatives and the use thereof as medicament | |
JP2013510081A (ja) | 向知性作用を有する2−(5−メチル−2−オキソ−4−フェニル−ピロリジン−1−イル)−アセトアミドの4r,5s−エナンチオマー | |
TWI644914B (zh) | 1,2,4-三唑并[4,3-a]吡啶化合物及其作為MGLUR2受體之正向異位調節劑的用途 | |
WO2008103382A1 (en) | Method for assembling high-purity chemical libraries, compounds suppressing acetyl coenzyme a carboxylase activities discovered by same | |
DE69635798T2 (de) | 4-aminotetrahydrobenzisoxazole oder -isothiazole | |
TW202024035A (zh) | 用於製備(-)-琥珀酸西苯唑啉的新穎方法 | |
CN101365678A (zh) | 可用于治疗h3受体相关病症的h3受体调节剂 | |
WO2012123358A1 (en) | 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity | |
EA031089B1 (ru) | Кристаллический (2s)-3-[(3s,4s)-3-[(1r)-1-гидроксиэтил]-4-(4-метокси-3-{[1-(5-метилпиридин-2-ил)азетидин-3-ил]окси}фенил)-3-метилпирролидин-1-ил]-3-оксопропан-1,2-диол | |
ES2214147B1 (es) | Procedimiento de obtencion de un agente antiepileptico. | |
CN106892926A (zh) | 一种dpp‑iv抑制剂的中间体、其制备方法和通过其制备dpp‑iv抑制剂的方法 | |
Martini et al. | Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130527 |
|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20130726 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130726 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140701 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140930 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150324 |